Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 3,320 shares at $3.18 ($11K) on 2023-03-22, disclosed to the SEC on 2023-03-24.
Scheduled purchase ($11k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.18 | 1,458 | $5K | 42.1% |
| 2 | $3.43 | 1,862 | $6K | 57.9% |
| Total | $3.32 avg | 3,320 | $11K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |